GENEVA, Sept. 1 -- ORION BIOTECHNOLOGY HOLDING SA (15 Avenue Secheron1202 Geneva) filed a patent application (PCT/EP2025/054599) for "CCL5 VARIANTS FOR MODULATING GPR75" on Feb 20, 2025. With publication no. WO/2025/176787, the details related to the patent application was published on Aug 28, 2025.
Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).
Inventor(s): HARTLEY, Oliver (12 chemin Lullin1256 Troinex)
Abstract:
The disclosure provides methods and uses of CCL5 variants for modulating GPR75 signaling in a cell or subject, treating a GPR75-related disease or disorder in a subject, treating obesity, hyperte...